Sustainable nanophytosome-based therapies against multidrug-resistant Escherichia coli in urinary tract infections: an in Vitro and in vivo study

被引:0
|
作者
Wen, Ming Ming [1 ]
Abdelwahab, Ibrahim A. [2 ]
Abozahra, Rania [3 ]
Abdelhamid, Sarah M. [3 ]
Baraka, Kholoud [3 ]
Ahmed, Heba Essam Sedky [4 ]
El-Hadidy, Wessam F. [4 ]
机构
[1] Pharos Univ Alexandria, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Alexandria, Egypt
[2] Pharos Univ Alexandria, Fac Pharm, Dept Microbiol & Immunol, Alexandria, Egypt
[3] Damanhour Univ, Fac Pharm, Dept Microbiol & Immunol, Damanhour, Egypt
[4] Alexandria Univ, Med Res Inst, Dept Pharmacol & Expt Therapeut, Alexandria, Egypt
关键词
Nanophytosomes; Rosemary oil; Escherichia coli; Chitosan; Urinary tract infection; Multidrug resistance; Drug delivery; Sustainability; Herbal medicine; Nanoparticle; CHITOSAN NANOPARTICLES; ESSENTIAL OILS; ROSEMARY; EPIDEMIOLOGY; FORMULATION; MECHANISMS; COMPONENTS; BIOFILM; THYME; ACID;
D O I
10.1186/s12951-024-03006-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Urinary tract infection (UTI) is a prevalent bacterial infection impacting a significant number of individuals globally. The rise in multidrug-resistant (MDR) E. coli strains as the predominant cause of UTIs presents a substantial public health concern and poses a challenge to existing antibiotic treatments. This study introduces an innovative and sustainable therapeutic approach utilizing rosemary oil nanophytosomes as a targeted drug delivery system to address biofilms in UTIs induced by MDR E. coli. Method Seventy clinically identified E. coli isolates from UTI patients were used for this study. Nanophytosomes were formulated with chitosan (CS) and nanostructured lipid carriers. CS-nanophytosomes were lyophilized to evaluate the storage stability. In vivo study included 40 female Wistar rats with daily treatment over seven days. For all the statistical tests, differences were considered significant at p < 0.01 and highly significant at p < 0.001. Results CS-nanophytosomes demonstrated a particle size of 176.70 +/- 12.30 nm with a substantial antibiofilm efficacy against MDR E. coli. High entrapment efficiency was ascertained with 93.12 +/- 1.05%. The drug release study showed that the pure rosemary oil exhibited a notably lower release of 35.4 +/- 2.36% over 48 h. In contrast, the CS-nanophytosomes and lyophilized CS-nanophytosomes displayed significantly higher release percentages of 58.6 +/- 3.69% and 56.9 +/- 5.01%, respectively, compared to the pure rosemary oil of 35.4 +/- 2.36% over 48 h. The in vivo study indicated that nanophytosomes successfully reduced the bacterial load in the urine, bladder, and kidney tissues of mice infected with MDR E. coli, while also lowering the levels of inflammatory cytokines and oxidative stress markers in serum and urine samples. Additionally, the nanophytosomes improved histopathological changes in bladder and kidney tissues caused by UTI without causing any toxicity or adverse effects on kidney function or hematological parameters. Conclusion Our research introduces a cost-effective and innovative approach to addressing UTIs caused by MDR E. coli by the use of rosemary oil, a natural antimicrobial agent encapsulated in nanophytosomes. This strategy not only demonstrates proven therapeutic efficacy in UTI animal models but also promotes the adoption of sustainable medical approaches. CS-nanophytosomes provides a sustainable alternative therapeutic option to combat MDR UTIs.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs
    Sanchez, S
    Stevenson, MAM
    Hudson, CR
    Maier, M
    Buffington, T
    Dam, Q
    Maurer, JJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3586 - 3595
  • [42] Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections
    Shigemura, Katsumi
    Arakawa, Soichi
    Miura, Tetsuya
    Nakano, Yuzo
    Tanaka, Kazushi
    Fujisawa, Masato
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2008, 61 (03) : 226 - 228
  • [43] In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli
    Spanu, Teresa
    De Angelis, Giulia
    Cipriani, Michela
    Pedruzzi, Barbara
    D'Inzeo, Tiziana
    Cataldo, Maria Adriana
    Sganga, Gabriele
    Tacconelli, Evelina
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4516 - 4518
  • [44] Antimicrobial activity of cinnamaldehyde against multidrug-resistant Klebsiella pneumoniae: an in vitro and in vivo study
    Mattos Vaz, Marcia Soares
    de Almeida de Souza, Gleyce Hellen
    dos Santos Radai, Joyce Alencar
    Fraga, Thiago Leite
    de Oliveira, Gustavo Gomes
    Wender, Heberton
    da Silva, Kesia Esther
    Simionatto, Simone
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2023, 54 (03) : 1655 - 1664
  • [45] Antimicrobial activity of cinnamaldehyde against multidrug-resistant Klebsiella pneumoniae: an in vitro and in vivo study
    Marcia Soares Mattos Vaz
    Gleyce Hellen de Almeida de Souza
    Joyce Alencar dos Santos Radai
    Thiago Leite Fraga
    Gustavo Gomes de Oliveira
    Heberton Wender
    Kesia Esther da Silva
    Simone Simionatto
    Brazilian Journal of Microbiology, 2023, 54 : 1655 - 1664
  • [46] Antimicrobial Activity of Peptidomimetics against Multidrug-Resistant Escherichia coli: A Comparative Study of Different Backbones
    Jahnsen, Rasmus D.
    Frimodt-Moller, Niels
    Franzyk, Henrik
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) : 7253 - 7261
  • [47] Multidrug-Resistant Escherichia coli Causing Urinary Tract Infections among Controlled and Uncontrolled Type 2 Diabetic Patients at Laquintinie Hospital in Douala, Cameroon
    Lambou, Josiane Claire Sonkoue
    Noubom, Michel
    Gomseu, Boris Emmanuel Djoumsie
    Marbou, Wiliane Jean Takougoum
    Tamokou, Jean-De-Dieu
    Gatsing, Donatien
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [48] Multidrug-resistant Uro-associated Escherichia coli Populations and Recurrent Urinary Tract Infections in Patients Performing Clean Intermittent Self-catheterisation
    Mowbray, Catherine
    Tan, Aaron
    Vallee, Maxime
    Fisher, Holly
    Chadwick, Thomas
    Brennand, Catherine
    Walton, Katherine E.
    Pickard, Robert S.
    Harding, Christopher
    Aldridge, Phillip D.
    Hall, Judith
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 37 : 90 - 98
  • [49] Antibiofilm Activity of Sundew Species against Multidrug-Resistant Escherichia coli Strains
    Gerschler, Sandy
    Guenther, Sebastian
    Schulze, Christian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [50] Synergistic Activity of Fluoroquinolones Combining with Artesunate Against Multidrug-Resistant Escherichia coli
    Wei, SiMin
    Yang, YueFei
    Tian, Wei
    Liu, MingJiang
    Yin, ShaoJie
    Li, JinGui
    MICROBIAL DRUG RESISTANCE, 2020, 26 (01) : 81 - 88